BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 22265038)

  • 1. Fertility preservation for social indications: a cost-based decision analysis.
    Hirshfeld-Cytron J; Grobman WA; Milad MP
    Fertil Steril; 2012 Mar; 97(3):665-70. PubMed ID: 22265038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding reproductive lifespan: a cost-effectiveness study on oocyte freezing.
    van Loendersloot LL; Moolenaar LM; Mol BW; Repping S; van der Veen F; Goddijn M
    Hum Reprod; 2011 Nov; 26(11):3054-60. PubMed ID: 21896545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth.
    Devine K; Mumford SL; Goldman KN; Hodes-Wertz B; Druckenmiller S; Propst AM; Noyes N
    Fertil Steril; 2015 Jun; 103(6):1446-53.e1-2. PubMed ID: 25813281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
    Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
    Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of oocyte cryopreservation: a meta-analysis.
    Oktay K; Cil AP; Bang H
    Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte cryopreservation versus ovarian tissue cryopreservation for adult female oncofertility patients: a cost-effectiveness study.
    Chung EH; Lim SL; Myers E; Moss HA; Acharya KS
    J Assist Reprod Genet; 2021 Sep; 38(9):2435-2443. PubMed ID: 33977465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal timing for elective egg freezing.
    Mesen TB; Mersereau JE; Kane JB; Steiner AZ
    Fertil Steril; 2015 Jun; 103(6):1551-6.e1-4. PubMed ID: 25881876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
    Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
    Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oocyte vitrification for elective fertility preservation: the past, present, and future.
    Gunnala V; Schattman G
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):59-63. PubMed ID: 27922944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue.
    Dueholm Hjorth IM; Kristensen SG; Dueholm M; Humaidan P
    Fertil Steril; 2020 Aug; 114(2):379-387. PubMed ID: 32624219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocyte vitrification as an efficient option for elective fertility preservation.
    Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
    Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria.
    Meirow D; Ra'anani H; Shapira M; Brenghausen M; Derech Chaim S; Aviel-Ronen S; Amariglio N; Schiff E; Orvieto R; Dor J
    Fertil Steril; 2016 Aug; 106(2):467-74. PubMed ID: 27181924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology?
    Gilbert K; Nangia AK; Dupree JM; Smith JF; Mehta A
    Urol Oncol; 2018 Mar; 36(3):92.e1-92.e9. PubMed ID: 29169844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience.
    Oktay K; Oktem O
    Fertil Steril; 2010 Feb; 93(3):762-8. PubMed ID: 19013568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation for healthy women: ethical aspects.
    Dondorp WJ; De Wert GM
    Hum Reprod; 2009 Aug; 24(8):1779-85. PubMed ID: 19386632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification.
    Sánchez-Serrano M; Crespo J; Mirabet V; Cobo AC; Escribá MJ; Simón C; Pellicer A
    Fertil Steril; 2010 Jan; 93(1):268.e11-3. PubMed ID: 19880105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markov modeling of vasectomy reversal and ART for infertility: how do obstructive interval and female partner age influence cost effectiveness?
    Hsieh MH; Meng MV; Turek PJ
    Fertil Steril; 2007 Oct; 88(4):840-6. PubMed ID: 17544418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.
    Huang JY; Tulandi T; Holzer H; Tan SL; Chian RC
    Fertil Steril; 2008 Mar; 89(3):567-72. PubMed ID: 17543957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.